SCHEMBL7054592

SCHEMBL7054592

COc1ccc(-c2cc(-c3ccc(OC)cc3)n(-c3ccccc3S(N)(=O)=O)n2)cc1.Cc1ccc(-c2cc(-c3ccc(Cl)cc3)n(-c3ccccc3S(N)(=O)=O)n2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.63
PTGS1 P23219 4/20 0.63
CYP2C9 P11712 2/20 0.51
EGFR P00533 1/20 0.43
NPY5R Q15761 1/20 0.43
CCKAR P32238 2/20 0.42
CACNA1B Q00975 2/20 0.41
CACNB4 O00305 1/20 0.41
CACNA1A O00555 1/20 0.41
CACNA1G O43497 1/20 0.41
CACNG3 O60359 1/20 0.41
CACNA1F O60840 1/20 0.41
CACNA1H O95180 1/20 0.41
CACNB3 P54284 1/20 0.41
CACNA2D1 P54289 1/20 0.41
CACNG7 P62955 1/20 0.41
CACNA1D Q01668 1/20 0.41
CACNB1 Q02641 1/20 0.41
CACNG1 Q06432 1/20 0.41
CACNB2 Q08289 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8420715 0.96 PTGS2 (0.67) PTGS2PTGS1CYP2C9EGFRCACNA1B
SCHEMBL8422298 0.93 CYP2C9 (0.57) PTGS2PTGS1CYP2C9EGFRNPY5R
SCHEMBL8424076 0.93 CYP2C9 (0.57) PTGS2PTGS1CYP2C9EGFRNPY5R
SCHEMBL6903209 0.91 CYP2C9 (0.61) PTGS2PTGS1CYP2C9EGFRNPY5R
SCHEMBL8420267 0.91 PTGS2 (0.58) PTGS2PTGS1CYP2C9EGFRNPY5R
SCHEMBL8420750 0.87 CYP2C9 (0.63) PTGS2PTGS1CYP2C9EGFRNPY5R
SCHEMBL8421778 0.87 PTGS2 (0.56) PTGS2PTGS1CYP2C9
SCHEMBL8420860 0.87 PTGS2 (0.56) PTGS2PTGS1CYP2C9EGFR
SCHEMBL8421509 0.86 PTGS2 (0.50) PTGS2PTGS1CYP2C9CACNA1BCACNB4
SCHEMBL8733829 0.85 PTGS2 (0.54) PTGS2PTGS1CYP2C9EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1443967-A1 CYCLOOXYGENASE-2 INHIBITOR/HISTONE DEACETYLASE INHIBITOR COMBINATION Novartis AG (CH) 2004-08-11 EP disclosed
WO-2003039599-A1 CYCLOOXYGENASE-2 INHIBITOR/HISTONE DEACETYLASE INHIBITOR COMBINATION NOVARTIS AG (CH) 2003-05-15 WO disclosed